Loading...
Header Logo
Keywords
Last Name
Institution

Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain.

Wagenaar TR, Ma L, Roscoe B, Park SM, Bolon DN, Green MR. Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. Pigment Cell Melanoma Res. 2014 Jan; 27(1):124-33.

View in: PubMed